Cefepime Injection
Last Updated: July 3, 2017
Status: Current
Cefepime Injection
-
Maxipime powder for solution for injection, Pfizer
2 gram, vial, 10 count (NDC 60505-0681-04)
1 gram/50 mL, premixed bag, 24 count (NDC 00264-3193-11)
1 gram/50 mL, premixed bag, 24 count (NDC 00338-1301-41)
1 gram, vial, 10 count (NDC 25021-0121-20)
-
- Apotex could not provide a reason for the shortage.
- Baxter had cefepime on shortage due to increased demand.
- BBraun has cefepime on shortage due to increased demand.
- Fresenius Kabi has cefepime injection on shortage due to manufacturing delays.
- Pfizer has Maxipime on shortage due to manufacturing delays.
- Sagent has cefepime injection on shortage due to manufacturing delays.
- Sandoz discontinued cefepime injection in early-2016.
- WG Critical Care had cefepime injection on shortage due to increased demand
-
Maxipime powder for solution for injection, Pfizer
1 gram, vial, 10 count (NDC 00409-0219-01)
2 gram, vial, 10 count (NDC 00409-0220-01)
1 gram, vial, 1 count (NDC 60505-0834-00)
1 gram, vial, 10 count (NDC 60505-0834-04)
2 gram/100 mL, premixed bag, 24 count (NDC 00264-3195-11)
1 gram/50 mL, premixed bag, 24 count (NDC 00338-1301-41)
2 gram, vial, 10 count (NDC 63323-0340-20)
1 gram, vial, 10 count (NDC 44567-0240-10)
2 gram, vial, 10 count (NDC 44567-0241-10)
Estimated Resupply Dates
-
- Apotex has cefepime 2 gram vials in 10 count on back order and the company estimates a release date in mid-July 2017.
- BBraun has cefepime 1 gram premixed bags on back order and the company cannot estimate a release date.
- Pfizer has Maxipime 1 gram ADD-Vantage vials on back order and the company estimates a release date of July 2017. The 2 gram ADD-Vantage vials are on back order and the company estimates a release date of August 2017.
- Sagent has cefepime 1 gram vials on allocation. The 2 gram vials are on back order and the company estimates a release date of July 2017.
| Acetaminophen and Codeine Phosphate 300 mg/30 mg Tablets | Resolved |
| Dexmethylphenidate Hydrochloride | Resolved |
| Flumazenil Injection | Resolved |
| Levorphanol Tablets | Resolved |
| Methylphenidate Hydrochloride Chewable Tablets | Current |
| Methylphenidate Hydrochloride Extended Release Oral Presentations | Resolved |
| Methylphenidate Hydrochloride Immediate Release Tablets | Resolved |
| Methylphenidate Transdermal | Current |
| Pramipexole Dihydrochloride Tablets | Resolved |
| Reserpine Oral Tablets | No Longer Available No Commercially Available Preparations |
| Rotigotine Transdermal Systems (Neupro) | Resolved |
Updated
July 3, June 27 and 14, May 5, April 6, March 30 and 8, February 22 and 6, January 18 and 6, 2017; December 9 and 1, November 4, October 17 and 4, September 7, August 25 and 2, June 24 and 21, May 27, 26, 16 and 9, April 13 and 6, February 29, 26 and 2, January 14 and 12, 2016; December 23, 17, 16 and 11, November 3, October 20, September 23, 14 and 3, August 11, July 28 and 14, June 29, 17, 11, 8 and 3, May 21 and 12, April 17 and 3, 2015, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
